You are here: Welcome » Medical Publications

Differences

This shows you the differences between two versions of the page.

Link to this comparison view

Both sides previous revisionPrevious revision
Next revision		Previous revision
Both sides next revision
medical_publications [2021/12/06 14:20]
robert [Covid-19 Publications & Regulatory Announcements: Organised Link Dump] 		medical_publications [2021/12/08 18:24] (current)
brian [Covid-19 Publications & Regulatory Announcements: Organised Link Dump]
Line 58: Line 58:
  
 [[https://www.ahajournals.org/doi/10.1161/circ.144.suppl_1.10712|Abstract 10712: Mrna COVID Vaccines Dramatically Increase Endothelial Inflammatory Markers and ACS Risk as Measured by the PULS Cardiac Test: a Warning]] \\ [[https://www.ahajournals.org/doi/10.1161/circ.144.suppl_1.10712|Abstract 10712: Mrna COVID Vaccines Dramatically Increase Endothelial Inflammatory Markers and ACS Risk as Measured by the PULS Cardiac Test: a Warning]] \\
 +
  
  
Line 66: Line 67:
 [[https://www.medrxiv.org/content/10.1101/2020.07.09.20143339v2|Association between SSRI Antidepressant Use and Reduced Risk of Intubation or Death in Hospitalized Patients with Coronavirus Disease 2019: a Multicenter Retrospective Observational Study]] \\ [[https://www.medrxiv.org/content/10.1101/2020.07.09.20143339v2|Association between SSRI Antidepressant Use and Reduced Risk of Intubation or Death in Hospitalized Patients with Coronavirus Disease 2019: a Multicenter Retrospective Observational Study]] \\
  
 +** Risk of Hospitalization, severe disease, and mortality due to COVID-19 ** \\
 +
 +[[https://www.medrxiv.org/content/10.1101/2021.11.30.21267048v1|Risk of Hospitalization, severe disease, and mortality due to COVID-19 and PIMS-TS in children with SARS-CoV-2 infection in Germany]] \\
  
 ** Vaccine Development & Approval ** ** Vaccine Development & Approval **
Line 103: Line 107:
  
 [[https://documentcloud.adobe.com/link/review?uri=urn:aaid:scds:US:72f49401-d242-44fb-9a2b-eaacf887cb61#pageNum=1 | SARS-CoV-2 prion-like domains in spike proteins enable higher affinity to ACE2 (not peer reviewed)]]. [[https://documentcloud.adobe.com/link/review?uri=urn:aaid:scds:US:72f49401-d242-44fb-9a2b-eaacf887cb61#pageNum=1 | SARS-CoV-2 prion-like domains in spike proteins enable higher affinity to ACE2 (not peer reviewed)]].
 +
 +[[https://www.researchgate.net/publication/356756711_Latest_statistics_on_England_mortality_data_suggest_systematic_mis-categorisation_of_vaccine_status_and_uncertain_effectiveness_of_Covid-19_vaccination | Latest statistics (December 2021) on England mortality data suggest systematic mis-categorisation of vaccine status and uncertain effectiveness of Covid-19 vaccination]].
  
 [[https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(21)00648-4/fulltext | An investigation into the transmission and viral load kinetics in vaccinated and unvaccinated individuals with mild delta variant infection in the community]]. [[https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(21)00648-4/fulltext | An investigation into the transmission and viral load kinetics in vaccinated and unvaccinated individuals with mild delta variant infection in the community]].
Line 136: Line 142:
 [[https://www.nature.com/articles/s41564-021-00954-4|SARS-CoV-2 variant prediction and antiviral drug design are enabled by RBD in vitro evolution]] \\ [[https://www.nature.com/articles/s41564-021-00954-4|SARS-CoV-2 variant prediction and antiviral drug design are enabled by RBD in vitro evolution]] \\
  
 +[[https://www.sciencedirect.com/science/article/pii/S0048969721071485?via%3Dihub|CD147-spike protein interaction in COVID-19: Get the ball rolling with a novel receptor and therapeutic target]] \\
  
  
Back to top